# OnCo record clonoseq (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/clonoseq/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "clonoseq" ;
  schema:name "clonoSEQ"@en ;
  schema:description "A DNA test that counts leftover leukaemia, myeloma or lymphoma cells down to one in a million, used to decide whether treatment has really worked."@en ;
  schema:url <https://onco.cc/drugs/clonoseq/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN170080>, <https://www.clonoseq.com> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "NGS minimal residual disease test (immunoglobulin and T-cell receptor clonotypes)" ;
  schema:alternateName "clonoSEQ" ;
  onco:approval "US 2018: MRD in bone marrow, B-cell acute lymphoblastic leukaemia and multiple myeloma (De Novo)", "US 2020: MRD in chronic lymphocytic leukaemia" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/ngs-mrd-clonoseq/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:companies <https://onco.cc/companies/adaptive-biotechnologies/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/mrd-negativity-myeloma/>, <https://onco.cc/terms/umrd/>, <https://onco.cc/terms/mrd-negative-cr/> ;
  onco:trials <https://onco.cc/trials/nct06483100/>, <https://onco.cc/trials/nct06828991/>, <https://onco.cc/trials/nct06252675/> .